Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2017

Open Access 01-12-2017 | Research article

The cardioprotective and antiarrhythmic effects of Nardostachys chinensis in animal and cell experiments

Authors: Min Li, Xue Xu, Xinyu Yang, Joey S. W. Kwong, Hongcai Shang

Published in: BMC Complementary Medicine and Therapies | Issue 1/2017

Login to get access

Abstract

Background

Cardiovascular disease (CVD) is the leading cause of premature death throughout the world. An estimated 17.5 million people died from CVD in 2012, representing 31% of all global deaths. Nardostachys chinensis (NC), a typical traditional Chinese medicine (TCM), plays a crucial role in the management of patients with CVD, especially for those with cardiac arrhythmia. The purpose of this study was to evaluate the cardioprotective and antiarrhythmic effects of NC in animal and cell experiments.

Methods

To review the cardioprotective and antiarrhythmic effects of NC, studies of NC on cardiovascular diseases in animal and cell experiments were identified from five databases through April 2016. Two investigators independently conducted the literature search, study selection, and data extraction.

Results

A total of 16 studies were identified, including five animal experiments and eleven cell experiments. Four studies showed significant effects of NC on myocardial protection by inhibiting myocardial apoptosis, inflammation and oxidative stress. Twelve studies indicated significant beneficial effects of NC in cardiac arrhythmia primarily through the modulation of ion channels (Ik, Ik1, INa, ICa-L, Ito).

Conclusion

The above findings showed the possible efficacy of NC via its cardioprotective and antiarrhythmic effects, but the results should be interpreted with caution due to the limitations and the deficiencies in the studies.
Literature
1.
go back to reference Riaz M, Zia-Ul-Haq M, Saad B. The Role of Anthocyanins in Health as Antioxidant, in Bone Health and as Heart Protecting Agents In: Anthocyanins and Human Health: Biomolecular and Therapeutic Aspects: Springer International Publishing; 2016. Riaz M, Zia-Ul-Haq M, Saad B. The Role of Anthocyanins in Health as Antioxidant, in Bone Health and as Heart Protecting Agents In: Anthocyanins and Human Health: Biomolecular and Therapeutic Aspects: Springer International Publishing; 2016.
2.
go back to reference Yang B, Benzhi C. Advances in the study of arrhythmogenic mechanisms. Journal of International Pharmaceutical Research. 2010;37(2):81–8. Yang B, Benzhi C. Advances in the study of arrhythmogenic mechanisms. Journal of International Pharmaceutical Research. 2010;37(2):81–8.
3.
go back to reference Nattel S, Andrade J, Macle L, Rivard L, Dyrda K, Mondesert B, et al. New directions in cardiac arrhythmia management: present challenges and future solutions. Can J Cardiol. 2014;30:S420–30.CrossRefPubMed Nattel S, Andrade J, Macle L, Rivard L, Dyrda K, Mondesert B, et al. New directions in cardiac arrhythmia management: present challenges and future solutions. Can J Cardiol. 2014;30:S420–30.CrossRefPubMed
5.
go back to reference Yousuf O, Chrispin J, Tomaselli GF, Berger RD. Clinical management and prevention of suddencardiac death. Circulation Research. 2015;116(12):2020–40.PubMed Yousuf O, Chrispin J, Tomaselli GF, Berger RD. Clinical management and prevention of suddencardiac death. Circulation Research. 2015;116(12):2020–40.PubMed
6.
go back to reference Lüderitz B. History of cardiac rhythm disorders. Z Kardiol. 2002;91(Suppl 4):50–5.PubMed Lüderitz B. History of cardiac rhythm disorders. Z Kardiol. 2002;91(Suppl 4):50–5.PubMed
7.
go back to reference Sanguinetti MC, Bennett PB. Antiarrhythmic drug target choices and screening. Circ Res. 2003;93(6):491–9.CrossRefPubMed Sanguinetti MC, Bennett PB. Antiarrhythmic drug target choices and screening. Circ Res. 2003;93(6):491–9.CrossRefPubMed
8.
go back to reference Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of Arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators.1989;321(6):406-12. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of Arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators.1989;321(6):406-12.
9.
go back to reference Nautiyal BP, Chauhan RS, Prakash V, Purohit H, Nautiyal MC. Population studies for the evaluation of germplasm and threat status of the alpine medicinal herb Nardostachys jatamansi. Journal of Statistical Physics. 2003;48(3-4):901–17. Nautiyal BP, Chauhan RS, Prakash V, Purohit H, Nautiyal MC. Population studies for the evaluation of germplasm and threat status of the alpine medicinal herb Nardostachys jatamansi. Journal of Statistical Physics. 2003;48(3-4):901–17.
10.
go back to reference The Pharmacopoeia of the People’s Republic of China. Pt 1. 2015:86. The Pharmacopoeia of the People’s Republic of China. Pt 1. 2015:86.
11.
go back to reference Yuan jie, Han Zucheng, Wang Min, Chen Qing. The research situation of Nardostachys chinensis. Chinese Journal of Ethnomedicine and Ethnopharmacy. 2012;21(16), 57-59. Yuan jie, Han Zucheng, Wang Min, Chen Qing. The research situation of Nardostachys chinensis. Chinese Journal of Ethnomedicine and Ethnopharmacy. 2012;21(16), 57-59.
12.
go back to reference Itokawa H, Masuyama K, Morita H, Takeya K. Cytotoxic sesquiterpenes from Nardostachys chinensis. Chem Pharm Bull (Tokyo). 1993;41(6):1183–4.CrossRefPubMed Itokawa H, Masuyama K, Morita H, Takeya K. Cytotoxic sesquiterpenes from Nardostachys chinensis. Chem Pharm Bull (Tokyo). 1993;41(6):1183–4.CrossRefPubMed
13.
go back to reference Li L, Wang Y. The study on the active components of Nardostachys chinensis. Journal of Capital Normal University (Natural Science Edition). 2010;31(6):31–4. Li L, Wang Y. The study on the active components of Nardostachys chinensis. Journal of Capital Normal University (Natural Science Edition). 2010;31(6):31–4.
14.
go back to reference Zhibin C, Fen L, Jiakun H, Yongping H. Pharmacological screening of antiarrhythmic fractions from Nardostachyson. Journal of Southwest University for Nationalities- Natural Science Edition. 2008;34(3):504–6. Zhibin C, Fen L, Jiakun H, Yongping H. Pharmacological screening of antiarrhythmic fractions from Nardostachyson. Journal of Southwest University for Nationalities- Natural Science Edition. 2008;34(3):504–6.
15.
go back to reference Hua W, Gao RL, Zhao BC, Wang J, Chen XH, Cai C, et al. The Efficacy and Safety of Wenxin Keli in Patients with Frequent Premature Ventricular Contractions: A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Trial. Chin Med J (Engl). 2015;128(19):2557–64.CrossRefPubMedPubMedCentral Hua W, Gao RL, Zhao BC, Wang J, Chen XH, Cai C, et al. The Efficacy and Safety of Wenxin Keli in Patients with Frequent Premature Ventricular Contractions: A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Trial. Chin Med J (Engl). 2015;128(19):2557–64.CrossRefPubMedPubMedCentral
16.
go back to reference Hu D, Barajas-Martínez H, Burashnikov A, Panama BK, Cordeiro JM, Antzelevitch C. Mechanisms underlying atrial-selective block of sodium channels by Wenxin Keli: Experimental and theoretical analysis. Int J Cardiol. 2016;207:326–34.CrossRefPubMedPubMedCentral Hu D, Barajas-Martínez H, Burashnikov A, Panama BK, Cordeiro JM, Antzelevitch C. Mechanisms underlying atrial-selective block of sodium channels by Wenxin Keli: Experimental and theoretical analysis. Int J Cardiol. 2016;207:326–34.CrossRefPubMedPubMedCentral
17.
go back to reference Gu CH, Wu YL, Tian SY, Gao X, Qi X, Jia Z, et al. Effect of shensong yangxin capsule on ventricular premature beat and cardiovascular autonomic nervous function in patients with coronary heart disease. Zhong guo Zhong Xi Yi Jie He Za Zhi. 2005;25(9):783–6. Gu CH, Wu YL, Tian SY, Gao X, Qi X, Jia Z, et al. Effect of shensong yangxin capsule on ventricular premature beat and cardiovascular autonomic nervous function in patients with coronary heart disease. Zhong guo Zhong Xi Yi Jie He Za Zhi. 2005;25(9):783–6.
18.
go back to reference Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE’s risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14:43.CrossRefPubMedPubMedCentral Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE’s risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14:43.CrossRefPubMedPubMedCentral
19.
go back to reference Yang T, Yuan Y, Xu M, Xiaoxia Z, Chuanhua B, Xu T. Effects of the volatile oil of Nardostachys chinensis administered at different time points on myocardial ischemia- reperfusion injury in rats. Chinese Journal of Hospital Pharmacy. 2012;32(23):1897–9. Yang T, Yuan Y, Xu M, Xiaoxia Z, Chuanhua B, Xu T. Effects of the volatile oil of Nardostachys chinensis administered at different time points on myocardial ischemia- reperfusion injury in rats. Chinese Journal of Hospital Pharmacy. 2012;32(23):1897–9.
20.
go back to reference Subashini R, Yogeeta S, Gnanapragasam A, Devaki T. Protective effect of Nardostachys jatamansi on oxidative injury and cellular abnormalities during doxorubicin-induced cardiac damage in rats. J Pharm Pharmacol. 2006;58(2):257–62.CrossRefPubMed Subashini R, Yogeeta S, Gnanapragasam A, Devaki T. Protective effect of Nardostachys jatamansi on oxidative injury and cellular abnormalities during doxorubicin-induced cardiac damage in rats. J Pharm Pharmacol. 2006;58(2):257–62.CrossRefPubMed
21.
go back to reference Maiwulanjiang M, Chen J, Xin G, Gong AG, Miernisha A, Du CY, et al. The volatile oil of Nardostachyos Radix et Rhizoma inhibits the oxidative stress-induced cell injury via reactive oxygen species scavenging and Akt activation in H9c2 cardiomyocyte. J Ethnopharmacol. 2014;153(2):491–8.CrossRefPubMed Maiwulanjiang M, Chen J, Xin G, Gong AG, Miernisha A, Du CY, et al. The volatile oil of Nardostachyos Radix et Rhizoma inhibits the oxidative stress-induced cell injury via reactive oxygen species scavenging and Akt activation in H9c2 cardiomyocyte. J Ethnopharmacol. 2014;153(2):491–8.CrossRefPubMed
22.
go back to reference Meng Du, Kun Huang, Lu Gao, Yang L, Wang WS, Wang B, et al. Nardosinone Protects H9c2 Cardiac Cells from Angiotensin II-induced Hypertrophy. J Huazhong Univ Sci Technolog Med Sci. 2013;33(6):822-826. Meng Du, Kun Huang, Lu Gao, Yang L, Wang WS, Wang B, et al. Nardosinone Protects H9c2 Cardiac Cells from Angiotensin II-induced Hypertrophy. J Huazhong Univ Sci Technolog Med Sci. 2013;33(6):822-826.
23.
go back to reference Ping Z. Academic dissertation. The Effects of the Volatile Oil of Gan Song on Effective Refractory Period and value of corrected ERP of Myocardium of Rats. 2008; Ping Z. Academic dissertation. The Effects of the Volatile Oil of Gan Song on Effective Refractory Period and value of corrected ERP of Myocardium of Rats. 2008;
24.
go back to reference Peng J, Qinghai L, Lihua F. Experimental study on the inhibitory effect of nardosinone on myocardial cell in rats with tachyarrhythmia. The Chinese Journal of Clinical Pharmacology. 2015;31(22):2240–2. Peng J, Qinghai L, Lihua F. Experimental study on the inhibitory effect of nardosinone on myocardial cell in rats with tachyarrhythmia. The Chinese Journal of Clinical Pharmacology. 2015;31(22):2240–2.
25.
go back to reference Zhang J, Qiang CC, Li WJ, Liu LJ, Lin XX, Cheng YJ, et al. Effects of Nardostachys chinensis on Spontaneous Ventricular Arrhythmias in Rats With Acute Myocardial Infarction. J Cardiovasc Pharmacol. 2014;64(2):127–33.CrossRefPubMed Zhang J, Qiang CC, Li WJ, Liu LJ, Lin XX, Cheng YJ, et al. Effects of Nardostachys chinensis on Spontaneous Ventricular Arrhythmias in Rats With Acute Myocardial Infarction. J Cardiovasc Pharmacol. 2014;64(2):127–33.CrossRefPubMed
26.
go back to reference Yuxiang L, Luo J, Yuzhi G, Wang Y, Shuhua Z, Wu Z. The Effect of the volatile oil of Nardostachys chinensis on Ik and Ik1 in Isolated Ventricular Myocytes in Rats. Lishizhen Medicine and Materia Medical Research. 2013;24(8):1814–7. Yuxiang L, Luo J, Yuzhi G, Wang Y, Shuhua Z, Wu Z. The Effect of the volatile oil of Nardostachys chinensis on Ik and Ik1 in Isolated Ventricular Myocytes in Rats. Lishizhen Medicine and Materia Medical Research. 2013;24(8):1814–7.
27.
go back to reference Qizhu T, Zhengrong H, Xiteng S, Wang T, Shen D. The Effect of the extract of Nardostachys chinensis on Sodium and Calcium Channel in Isolated Ventricular Myocytes in Rats. Chinese Journal of Cardiology. 2004;32(z2):267–70. Qizhu T, Zhengrong H, Xiteng S, Wang T, Shen D. The Effect of the extract of Nardostachys chinensis on Sodium and Calcium Channel in Isolated Ventricular Myocytes in Rats. Chinese Journal of Cardiology. 2004;32(z2):267–70.
28.
go back to reference Ming C, Yuzhi G, Lu J, Wang Y, Shuhua Z, Wu Z. The Effect of the volatile oil of Nardostachys chinensis on L-Type Calcium Channel in Isolated Ventricular Myocytes in Rats. Lishizhen Medicine and Materia Medical Research. 2010;21(9):2264–6. Ming C, Yuzhi G, Lu J, Wang Y, Shuhua Z, Wu Z. The Effect of the volatile oil of Nardostachys chinensis on L-Type Calcium Channel in Isolated Ventricular Myocytes in Rats. Lishizhen Medicine and Materia Medical Research. 2010;21(9):2264–6.
29.
go back to reference Yuanwei L, Guo J, Ping Z, Jiwen L, Chun L. The effects of nardostachys chinensis batal extract on the sodium current and transient outward potassium current of rat ventricular myocytes. Chinese Journal of Cardiac Pacing and Electrophysiology. 2009;23(6):533–5. Yuanwei L, Guo J, Ping Z, Jiwen L, Chun L. The effects of nardostachys chinensis batal extract on the sodium current and transient outward potassium current of rat ventricular myocytes. Chinese Journal of Cardiac Pacing and Electrophysiology. 2009;23(6):533–5.
30.
go back to reference Yang T, Yuzhi G, Luo J, Hu L, Shuhua Z. The Effect of the volatile oil of Nardostachys chinensis on Sodium Channel in Isolated Ventricular Myocytes in Rats. Lishizhen Medicine and Materia Medical Research. 2010;21(2):284–5. Yang T, Yuzhi G, Luo J, Hu L, Shuhua Z. The Effect of the volatile oil of Nardostachys chinensis on Sodium Channel in Isolated Ventricular Myocytes in Rats. Lishizhen Medicine and Materia Medical Research. 2010;21(2):284–5.
31.
go back to reference Hu L, Yuzhi G, Luo J, Yang T, Shuhua Z. The Effect of the volatile oil of Nardostachys chinensis on Transient outward potassium current in Isolated Ventricular Myocytes in Rats. Lishizhen Medicine and Materia Medical Research. 2009;20(8):1843–5. Hu L, Yuzhi G, Luo J, Yang T, Shuhua Z. The Effect of the volatile oil of Nardostachys chinensis on Transient outward potassium current in Isolated Ventricular Myocytes in Rats. Lishizhen Medicine and Materia Medical Research. 2009;20(8):1843–5.
32.
go back to reference Yuzhi G, Zhiting W, Shuahua Z, Guotai S, Yeh Jay Z. Blockade of current of Nav1.5 in HEK cells depended by the voltage and concentration of volatile oil of Nardostachy Chinesis Btala. Pharmacology and Clinics of Chinese Materia Medical. 2009;25(3):30–2. Yuzhi G, Zhiting W, Shuahua Z, Guotai S, Yeh Jay Z. Blockade of current of Nav1.5 in HEK cells depended by the voltage and concentration of volatile oil of Nardostachy Chinesis Btala. Pharmacology and Clinics of Chinese Materia Medical. 2009;25(3):30–2.
33.
go back to reference Yuzhi G, Zhiting W, Langji H, Yeh Jay Z. The Effects of the Volatile Oil of Nardosta chychinesis Batal on Na+ Current of the Cardiac Sodium Channels of Rats and Nav1.5 in HEK Cells. Lishizhen Medicine and Materia Medical Research. 2009;20(1):1–3.CrossRef Yuzhi G, Zhiting W, Langji H, Yeh Jay Z. The Effects of the Volatile Oil of Nardosta chychinesis Batal on Na+ Current of the Cardiac Sodium Channels of Rats and Nav1.5 in HEK Cells. Lishizhen Medicine and Materia Medical Research. 2009;20(1):1–3.CrossRef
34.
go back to reference Yanyang L, Yuzhi G, Yeh JZ. The effects of Volatile 0il of Nardostachys Chinesis Batal (VONCB) on frequency-dependent block of Na+ channels (Nav1.5) in human embryonic kidney (HEK) cells. Lishizhen Medicine and Materia Medical. Research. 2013;24(1):15–6. Yanyang L, Yuzhi G, Yeh JZ. The effects of Volatile 0il of Nardostachys Chinesis Batal (VONCB) on frequency-dependent block of Na+ channels (Nav1.5) in human embryonic kidney (HEK) cells. Lishizhen Medicine and Materia Medical. Research. 2013;24(1):15–6.
35.
go back to reference Kovacic P, Somanathan R. Redox process in neurodegenerative disease involving reactive oxygen species. Current Neuropharmacology. 2012;10(4):289–302.CrossRefPubMedPubMedCentral Kovacic P, Somanathan R. Redox process in neurodegenerative disease involving reactive oxygen species. Current Neuropharmacology. 2012;10(4):289–302.CrossRefPubMedPubMedCentral
36.
go back to reference Ichihara S. The pathological roles of environmental and redox stresses in cardiovascular disease. Environmental Health and Preventive Medicine. 2013;18(3):177–84.CrossRefPubMed Ichihara S. The pathological roles of environmental and redox stresses in cardiovascular disease. Environmental Health and Preventive Medicine. 2013;18(3):177–84.CrossRefPubMed
37.
go back to reference Heineke J. Molkentin Jd. Regulation of cardiac hypertrophy by intracellular signaling pathways. Nat Rev. Mol Cell Biol. 2006;7(8):589–600. Heineke J. Molkentin Jd. Regulation of cardiac hypertrophy by intracellular signaling pathways. Nat Rev. Mol Cell Biol. 2006;7(8):589–600.
38.
go back to reference Hunyady L, Turu G. The role of the AT1 angiotensin receptor in cardiac hypertrophy: angiotensin II receptor or stretch sensor? Trends Endocrinol Metab. 2004;15(9):405–8.CrossRefPubMed Hunyady L, Turu G. The role of the AT1 angiotensin receptor in cardiac hypertrophy: angiotensin II receptor or stretch sensor? Trends Endocrinol Metab. 2004;15(9):405–8.CrossRefPubMed
39.
go back to reference Hung J, Teng TH, Finn J, Knuiman M, Briffa T, Stewart S, et al. Trends from 1996 to 2007 in incidence and mortality outcomes of heart failure after acute myocardial infarction: a population-based study of 20812 patients with first acute myocardial infarction in Western Australia. J Am Heart Assoc. 2013;2(5):e000172.CrossRefPubMedPubMedCentral Hung J, Teng TH, Finn J, Knuiman M, Briffa T, Stewart S, et al. Trends from 1996 to 2007 in incidence and mortality outcomes of heart failure after acute myocardial infarction: a population-based study of 20812 patients with first acute myocardial infarction in Western Australia. J Am Heart Assoc. 2013;2(5):e000172.CrossRefPubMedPubMedCentral
40.
go back to reference Rezkalla SH, Dharmashankar KC, Abdalrahman IB, Kloner RA. No-reflow phenomenon following percutaneous coronary intervention for acute myocardial infarction: incidence, outcome, and effect of pharmacologic therapy. J Interv Cardiol. 2010;23(5):429–36.CrossRefPubMed Rezkalla SH, Dharmashankar KC, Abdalrahman IB, Kloner RA. No-reflow phenomenon following percutaneous coronary intervention for acute myocardial infarction: incidence, outcome, and effect of pharmacologic therapy. J Interv Cardiol. 2010;23(5):429–36.CrossRefPubMed
41.
go back to reference Domburg RT, Hendriks JM, Kamp O, Smits P, Mv M, Schenkeveld L, et al. Three life years gained after reperfusion therapy in acute myocardial infarction: 25-30 years after a randomized controlled trial. Eur J Prev Cardiol. 2012;19(6):1316–23.CrossRefPubMed Domburg RT, Hendriks JM, Kamp O, Smits P, Mv M, Schenkeveld L, et al. Three life years gained after reperfusion therapy in acute myocardial infarction: 25-30 years after a randomized controlled trial. Eur J Prev Cardiol. 2012;19(6):1316–23.CrossRefPubMed
42.
43.
go back to reference O'Donoghue ML, Glaser R, Cavender MA, Aylward PE, Bonaca MP, Budaj A, et al. Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction: A Randomized Clinical Trial. JAMA. 2016;315(15):1591–9.CrossRefPubMed O'Donoghue ML, Glaser R, Cavender MA, Aylward PE, Bonaca MP, Budaj A, et al. Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction: A Randomized Clinical Trial. JAMA. 2016;315(15):1591–9.CrossRefPubMed
44.
go back to reference Iliodromitis K, Farmakis D, Andreadou I, Zoga A, Bibli SI, Manolaki T, et al. Various models of cardiac conditioning in single or sequential periods of ischemia: comparative effects on infarct size and intracellular signaling. Int J Cardiol. 2013;168(2):1336–41.CrossRefPubMed Iliodromitis K, Farmakis D, Andreadou I, Zoga A, Bibli SI, Manolaki T, et al. Various models of cardiac conditioning in single or sequential periods of ischemia: comparative effects on infarct size and intracellular signaling. Int J Cardiol. 2013;168(2):1336–41.CrossRefPubMed
45.
go back to reference Lefrak EA, Pitha J, Rosenheim S, Gottlieb JA. A clinicopathologic analysis of Adriamycin cardiotoxicity. Cancer. 1973;32(2):302–14.CrossRefPubMed Lefrak EA, Pitha J, Rosenheim S, Gottlieb JA. A clinicopathologic analysis of Adriamycin cardiotoxicity. Cancer. 1973;32(2):302–14.CrossRefPubMed
46.
go back to reference Nagi MN, Mansour MA. Protective effect of Thymoqui-none against Doxorubicin-induced cardiotoxicity in rats: a possible mechanism of protection. Pharmacol. Res. 2000;41(3):283–9.CrossRefPubMed Nagi MN, Mansour MA. Protective effect of Thymoqui-none against Doxorubicin-induced cardiotoxicity in rats: a possible mechanism of protection. Pharmacol. Res. 2000;41(3):283–9.CrossRefPubMed
47.
go back to reference Yoon J, Leblanc N, Zaklit J, Vernier PT, Chatterjee I, Craviso GL. Enhanced Monitoring of Nanosecond Electric Pulse-Evoked Membrane Conductance Changes in Whole-Cell Patch Clamp Experiments. J Membr Biol. 2016;249(5):633–44.CrossRefPubMed Yoon J, Leblanc N, Zaklit J, Vernier PT, Chatterjee I, Craviso GL. Enhanced Monitoring of Nanosecond Electric Pulse-Evoked Membrane Conductance Changes in Whole-Cell Patch Clamp Experiments. J Membr Biol. 2016;249(5):633–44.CrossRefPubMed
48.
go back to reference Decker KF, Rudy Y. Ionic mechanisms of electrophysiological heterogeneity and conduction block in the infarct border zone. Am J Physiol Heart Circ Physiol. 2010;299(5):H1588–97.CrossRefPubMedPubMedCentral Decker KF, Rudy Y. Ionic mechanisms of electrophysiological heterogeneity and conduction block in the infarct border zone. Am J Physiol Heart Circ Physiol. 2010;299(5):H1588–97.CrossRefPubMedPubMedCentral
50.
go back to reference O'Hara T, Rudy Y. Arrhythmia formation in subclinical (“silent”) long QT syndrome requires multiple insults: quantitative mechanistic study using the KCNQ1 mutation Q357R as example. Heart Rhythm. 2012;9(2):275–82.CrossRefPubMed O'Hara T, Rudy Y. Arrhythmia formation in subclinical (“silent”) long QT syndrome requires multiple insults: quantitative mechanistic study using the KCNQ1 mutation Q357R as example. Heart Rhythm. 2012;9(2):275–82.CrossRefPubMed
52.
go back to reference Barry DM, Xu H, Schuessler RB, Nerbonne JM. Functional knockout of the transient outward current, long-QT syndrome, and cardiac remodeling in mice expressing a dominant-negative Kv4 alpha subunit. Circ Res. 1998;83(5):560–7.CrossRefPubMed Barry DM, Xu H, Schuessler RB, Nerbonne JM. Functional knockout of the transient outward current, long-QT syndrome, and cardiac remodeling in mice expressing a dominant-negative Kv4 alpha subunit. Circ Res. 1998;83(5):560–7.CrossRefPubMed
53.
go back to reference Perrin MJ, Adler A, Green S, Al-Zoughool F, Doroshenko P, Orr N, et al. Evaluation of genes encoding for the transient outward current (Ito) identifies the KCND2 gene as a cause of J-wave syndrome associated with sudden cardiac death. Circ Cardiovasc Genet. 2014;7(6):782–9.CrossRefPubMed Perrin MJ, Adler A, Green S, Al-Zoughool F, Doroshenko P, Orr N, et al. Evaluation of genes encoding for the transient outward current (Ito) identifies the KCND2 gene as a cause of J-wave syndrome associated with sudden cardiac death. Circ Cardiovasc Genet. 2014;7(6):782–9.CrossRefPubMed
54.
go back to reference Ke Y, Lei M, Collins TP, Rakovic S, Mattick PA, Yamasaki M, et al. Regulation of L-type calcium channel and delayed rectifier potassium channel activity by p21-activated kinase-1 in guinea pig sinoatrial node pacemaker cells. Circ Res. 2007;100(9):1317–27.CrossRefPubMed Ke Y, Lei M, Collins TP, Rakovic S, Mattick PA, Yamasaki M, et al. Regulation of L-type calcium channel and delayed rectifier potassium channel activity by p21-activated kinase-1 in guinea pig sinoatrial node pacemaker cells. Circ Res. 2007;100(9):1317–27.CrossRefPubMed
55.
go back to reference Lape R, Nistri A. Characteristics of fast Na(+) current of hypoglossal motoneurons in a rat brainstem slice preparation. Eur J Neurosci. 2001;13(4):763–72.CrossRefPubMed Lape R, Nistri A. Characteristics of fast Na(+) current of hypoglossal motoneurons in a rat brainstem slice preparation. Eur J Neurosci. 2001;13(4):763–72.CrossRefPubMed
56.
go back to reference Guo D, Young L, Wu Y, Belardinelli L, Kowey PR, Yan GX. Increased late sodium current in left atrial myocytes of rabbits with left ventricular hypertrophy: its role in the genesis of atrial arrhythmias. Am J Physiol Heart Circ Physiol. 2010;298(5):H1375–81.CrossRefPubMed Guo D, Young L, Wu Y, Belardinelli L, Kowey PR, Yan GX. Increased late sodium current in left atrial myocytes of rabbits with left ventricular hypertrophy: its role in the genesis of atrial arrhythmias. Am J Physiol Heart Circ Physiol. 2010;298(5):H1375–81.CrossRefPubMed
57.
go back to reference Xue T, Siu CW, Lieu DK, Lau CP, Tse HF, Li RA. Mechanistic role of I(f) revealed by induction of ventricular automaticity by somatic gene transfer of gating-engineered pacemaker (HCN) channels. Circulation. 2007;115(14):1839–50.CrossRefPubMedPubMedCentral Xue T, Siu CW, Lieu DK, Lau CP, Tse HF, Li RA. Mechanistic role of I(f) revealed by induction of ventricular automaticity by somatic gene transfer of gating-engineered pacemaker (HCN) channels. Circulation. 2007;115(14):1839–50.CrossRefPubMedPubMedCentral
58.
go back to reference Rosenberg RL, Hess P, Tsien RW. Cardiac calcium channels in planar lipid bilayers. L-type channels and calcium-permeable channels open at negative membrane potentials. J Gen Physiol. 1988;92(1):27–54.CrossRefPubMed Rosenberg RL, Hess P, Tsien RW. Cardiac calcium channels in planar lipid bilayers. L-type channels and calcium-permeable channels open at negative membrane potentials. J Gen Physiol. 1988;92(1):27–54.CrossRefPubMed
59.
go back to reference Yamaoka K, Kameyama M. Regptulation of L-type Ca2+ channels in the heart: overview of recent advances. Mol Cell Biochem. 2003;253(1-2):3–13.CrossRefPubMed Yamaoka K, Kameyama M. Regptulation of L-type Ca2+ channels in the heart: overview of recent advances. Mol Cell Biochem. 2003;253(1-2):3–13.CrossRefPubMed
60.
go back to reference Ono K, Iijima T. Cardiac T-type Ca (2+) channels in the heart. J Mol Cell Cardiol. 2010;48(1):65–70.PubMed Ono K, Iijima T. Cardiac T-type Ca (2+) channels in the heart. J Mol Cell Cardiol. 2010;48(1):65–70.PubMed
61.
go back to reference Asakura K, Cha CY, Yamaoka H, Horikawa Y, Memida H, Powell T, Amano A, Noma A. EAD and DAD mechanisms analyzed by developing a new human ventricular cell model. Prog Biophys Mol Biol. 2014;116(1):11–24.CrossRefPubMed Asakura K, Cha CY, Yamaoka H, Horikawa Y, Memida H, Powell T, Amano A, Noma A. EAD and DAD mechanisms analyzed by developing a new human ventricular cell model. Prog Biophys Mol Biol. 2014;116(1):11–24.CrossRefPubMed
62.
63.
go back to reference Vaughan Williams EM. Classifying antiarrhythmic actions: by facts or speculation. J Clin Pharmacol. 1992;32(11):964–77.CrossRefPubMed Vaughan Williams EM. Classifying antiarrhythmic actions: by facts or speculation. J Clin Pharmacol. 1992;32(11):964–77.CrossRefPubMed
Metadata
Title
The cardioprotective and antiarrhythmic effects of Nardostachys chinensis in animal and cell experiments
Authors
Min Li
Xue Xu
Xinyu Yang
Joey S. W. Kwong
Hongcai Shang
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2017
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-017-1910-1

Other articles of this Issue 1/2017

BMC Complementary Medicine and Therapies 1/2017 Go to the issue